Triple therapy better than double therapy for COPD

In this large retrospective analysis of COPD patients, those on 3 inhaled drugs (steroid, long acting beta agonist and tiotropium) has worse baseline lung function, but 35% lower all cause mortality, compared to those on 2 drugs (steroid and long acting beta agonist).  This adds good evidence of benefit for 3 inhaled versus 2 inhaled drugs in lowering COPD mortality, although it has not been proven in a randomized controlled trial (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment